Literature DB >> 25881823

Silver(I) complexes of 2,4-dihydroxybenzaldehyde-amino acid Schiff bases-Novel noncompetitive α-glucosidase inhibitors.

Jingwei Zheng1, Lin Ma2.   

Abstract

A series of silver(I) complexes of 2,4-dihydroxybenzaldehyde-amino acid Schiff bases were designed and tested for α-glucosidase inhibition. Our results indicate that all the silver complexes (4a-18a) possessed strong inhibitory activity at μmolL(-1) level, especially glutamine (12a) and histidine (18a) Schiff base silver(I) complexes exhibited an IC50 value of less than 0.01μmolL(-1). This series of compounds exhibited noncompetitive inhibition characteristics in kinetic studies. In addition, we investigated the mechanism of inhibition and the structure-activity relationships of the amino acid Schiff base silver complexes. Our results reveal that Schiff base silver complexes may be explored for their therapeutic potential as alternatives of α-glucosidase inhibitors.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amino acid Schiff bases; Noncompetitive inhibitors; Silver(I) complexes; α-Glucosidase

Mesh:

Substances:

Year:  2015        PMID: 25881823     DOI: 10.1016/j.bmcl.2015.03.078

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  A novel series of mixed-ligand M(II) complexes containing 2,2'-bipyridyl as potent α-glucosidase inhibitor: synthesis, crystal structure, DFT calculations, and molecular docking.

Authors:  Davut Avcı; Sümeyye Altürk; Fatih Sönmez; Ömer Tamer; Adil Başoğlu; Yusuf Atalay; Belma Zengin Kurt; Necmi Dege
Journal:  J Biol Inorg Chem       Date:  2019-07-17       Impact factor: 3.358

2.  Novel metal complexes containing 6-methylpyridine-2-carboxylic acid as potent α-glucosidase inhibitor: synthesis, crystal structures, DFT calculations, and molecular docking.

Authors:  Davut Avcı; Sümeyye Altürk; Fatih Sönmez; Ömer Tamer; Adil Başoğlu; Yusuf Atalay; Belma Zengin Kurt; Necmi Dege
Journal:  Mol Divers       Date:  2020-01-21       Impact factor: 2.943

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.